Spatial modelling of malaria prevalence associated with geographical factors in Houet province of Burkina Faso, West Africa.

Malaria is a permanent threat to health in western Burkina Faso. Research has shown that geographical variables contribute to the spatial distribution in its transmission. The objective of this study is to assess the relationship between malaria prevalence and potential explanatory geographical variables in the Houet province in Burkina Faso. Statistics on malaria prevalence registered by health centres in the Houet province in 2017 and potential geographical variables identified through a literature review were collected. An Ordinary Least Squares (OLS) regression was used to identify key geographical variables and to measure their association with malaria while the Getis Ord Gi* index was used to locate malaria hotspots. The results showed that average annual temperature, vegetation density, percentage of clay in the soil, total annual rainfall and distance to the nearest waterbody are the main variables associated with malaria prevalence. These variables account for two-thirds of the spatial variability of malaria prevalence observed in Houet province. The intensity and direction of the relationship between malaria prevalence and geographical factors vary according to the variable. Hence, only vegetation density is positively correlated with malaria prevalence. Average temperature, for soil clay content, annual rainfall and for distance to the nearest water body are negatively correlated with the disease prevalence. These results show that even in an endemic area, malaria prevalence has significant spatial variation. The results could contribute to the choice of intervention sites, as this choice is crucial for reducing the malaria burden. Supplementary Information: The online version contains supplementary material available at 10.1007/s10708-022-10692-7.

Mark-release-recapture experiment in Burkina Faso demonstrates reduced fitness and dispersal of genetically-modified sterile malaria mosquitoes.

Every year, malaria kills approximately 405,000 people in Sub-Saharan Africa, most of them children under the age of five years. In many countries, progress in malaria control has been threatened by the rapid spread of resistance to antimalarial drugs and insecticides. Novel genetic mosquito control approaches could play an important role in future integrated malaria control strategies. In July 2019, the Target Malaria consortium proceeded with the first release of hemizygous genetically-modified (GM) sterile and non-transgenic sibling males of the malaria mosquito Anopheles coluzzii in Burkina Faso. This study aimed to determine the potential fitness cost associated to the transgene and gather important information related to the dynamic of transgene-carrying mosquitoes, crucial for next development steps. Bayesian estimations confirmed that GM males had lower survival and were less mobile than their wild type (WT) siblings. The estimated male population size in Bana village, at the time of the release was 28,000 - 37,000. These results provide unique information about the fitness and behaviour of released GM males that will inform future releases of more effective strains of the A. gambiae complex.

Preparing an Insectary in Burkina Faso to Support Research in Genetic Technologies for Malaria Control.

The Institut de Recherche en Sciences de la Santé (IRSS) of Burkina Faso, West Africa, was the first African institution to import transgenic mosquitoes for research purposes. A shift from the culture of mosquito research to regulated biotechnology research and considerable management capacity is needed to set up and run the first insectary for transgenic insects in a country that applied and adapted the existing biosafety framework, first developed for genetically modified (GM) crops, to this new area of research. The additional demands arise from the separate regulatory framework for biotechnology, referencing the Cartagena Protocol on Biosafety, and the novelty of the research strain, making public understanding and acceptance early in the research pathway important. The IRSS team carried out extensive preparations following recommendations for containment of GM arthropods and invested efforts in local community engagement and training with scientific colleagues throughout the region. Record keeping beyond routine practice was established to maintain evidence related to regulatory requirements and risk assumptions. The National Biosafety Agency of Burkina Faso, Agence Nationale de Biosécurité (ANB), granted the permits for import of the self-limiting transgenic mosquito strain, which took place in November 2016, and for conducting studies in the IRSS facility in Bobo-Dioulasso. Compliance with permit terms and conditions of the permits and study protocols continued until the conclusion of studies, when the transgenic colonies were terminated. All this required close coordination between management and the insectary teams, as well as others. This article outlines the experiences of the IRSS to support others undertaking such studies. The IRSS is contributing to the ongoing development of genetic technologies for malaria control, as a partner of Target Malaria. The ultimate objective of the innovation is to reduce malaria transmission by using GM mosquitoes of the same species released to reduce the disease-vectoring native populations of Anopheles gambiae s.l.